Multi-titer live vaccine as well as preparation method and application thereof
A live vaccine, multi-valence technology, applied in the field of preparation of multi-valence live vaccines, can solve problems such as multi-valence vibriosis live bacteria vaccines that have not yet been seen, and achieve obvious multi-valence immune protection and good application foreground effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0038] Example 1 , Recombinant plasmid construction
[0039] 1.1, primer design
[0040] Design primers hlyASP-F, hlyASP-R, rtxASP-F, rtxASP-R, vah3SP-F, vah3SP-R, empASP-F, empASP-R, gapA-F1 / 2, gapA-R1, gapA-R2, gapA- F3, gapA-F4 and gapA-R3 / 4, the sequence of the above primers and restriction sites are as follows:
[0041] hlyASP-F: 5′-CACTCAGCAGGACAAAGCACGAAAGATGCAT-3′;
[0042] hlyASP-R: 5′-CGC GGATCC TTATGCTGATGTGGTC-3';
[0043] BamHI site
[0044] rtxASP-F: 5'-GATTACTTTAATGGTAACCGCGCTCAAGTG-3';
[0045] rtxASP-R: 5′-TGC ATGCAT TTACACCATCAATCCTTTTTTGTG-3';
[0046] NsiI site
[0047] vah3SP-F: 5′-CCG GAATTC GATGACTTCTTCTAAATTTTCG-3';
[0048] EcoRI site
[0049] vah3SP-R: 5'-AGACCACTTTAATTGGGTGTTTATCTCACTAGGG-3';
[0050] empASP-F: 5′-CCG GAATTC GATGAAAAAAGTACAACGTC-3′;
[0051] EcoR I site
[0052] empASP-R: 5'-AGCTTGTTCTAGTAGACTTGGATCA-3'.
[0053] gapA-F1 / 2: 5′-TAGGA GAATTC GATGACTATCAAAGTAGG-3′;
[0054] EcoR I site
[0055] gapA-R1: 5'-CGTGCTTTGTCCTGCTGAGTGCTTAGAGATGTGAGCGAT-3'
[...
Example Embodiment
[0079] Example 2 , Construction of Recombinant Strains of Vibrio anguillarum
[0080] Inoculate Vibrio anguillarum MVAV6203 into 50ml high-salt LB culture medium, shake culture overnight at 30℃, and then transfer it to 100ml fresh high-salt LB culture medium at 1:100 (v / v) at 30℃ Incubate with shaking at 200 rpm to OD 600 When the value is 0.6, collect the bacteria by centrifugation, place the bacteria in an ice bath for 20-30 minutes, wash the bacteria three times with 272mM sucrose buffer, and then suspend the bacteria with sucrose buffer to make the final concentration of the bacteria 1 ×10 9 cfu / ml, to obtain the electrotransformation competent cells of Vibrio anguillarum MVAV6203.
[0081] The recombinant strains Top10 (pGap-hlyA), Top10 (pGap-rtxA), Top10 (pGap-vah3), Top10 (pGap-empA) and Top10 (pGap) were amplified and cultured, and the bacteria were collected and prepared to obtain the corresponding recombinant Plasmids pGap-hlyA, pGap-rtxA, pGap-vah3, pGap-empA and pGap...
Example Embodiment
[0085] Example 3 , Multi-titer live attenuated vaccine screening
[0086] The recombinant strains obtained in the steps of Example 2 were respectively inoculated into LB high-salt liquid medium containing 200μg / ml ampicillin, cultured at 200rpm and 30℃ overnight, and inoculated into 100ml at 1:100 (v / v) the next day LB high salt (Amp) medium was cultured at 30°C and 200 rpm for 9 hours, and the culture broth was harvested.
[0087] Centrifuge 1 ml of the harvested culture solution at 10,000 g for 10 min, and collect the supernatant as the "supernatant fraction".
[0088] At the same time, the bacterial pellet was washed three times with PBS (pH 7.0), and then resuspended in 1 ml PBS. The resuspension was sonicated in an ice bath for 5 min until the cells were completely broken, and then the obtained cell lysate was centrifuged at 4° C., 10,000 g for 5 min, and the supernatant was collected as the "intracellular fraction".
[0089] The obtained "supernatant fraction" and "intracellul...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap